ESMO 2025 special: Prof. Tagawa presents the PSMAddition trial results

from EAU Podcasts · host European Association of Urology

In this episode, Prof. Scott Tagawa (US), a medical oncologist at Weill Cornell Medicine in New York, discusses the results of PSMAddition - a phase III trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer. This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Episode metadata supplied by the publisher feed · Published Oct 23, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

ESMO 2025 special: Prof. Tagawa presents the PSMAddition trial results

0:00 11:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of EAU Podcasts?

This episode is 11 minutes long.

When was this EAU Podcasts episode published?

This episode was published on October 23, 2025.

Can I download this EAU Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!